-
October 15, 2019PREVIEW
Stopping statins used by older patients for primary prevention was associated with an increased risk of cardiovascular (CV) adverse events such as coronary, cerebrovascular, and other vascular...
-
June 18, 2019PREVIEW
Use of atorvastatin in patients at risk for or with established cardiovascular (CV) disease resulted in a modest dose-dependent improvement in kidney function over time. This improvement in kidney...
-
April 9, 2019PREVIEW
Statins produce a significant reduction in major vascular events in older adults, including those older than 75 years, and older adults with established vascular disease receive greater benefits...
-
February 19, 2019PREVIEW
Patients with hypertriglyceridemia on statin therapy who received icosapent ethyl (Vascepa—Amarin) had a significant reduction in adverse cardiovascular (CV) events compared with patients...
-
January 7, 2019PREVIEW
Adding alirocumab (Praluent—Sanofi, Regeneron) to high-intensity statin therapy for patients who had an acute coronary syndrome (ACS) in the preceding 12 months resulted in a significantly lower...
Pages
